Список литературы
1. Kudose S., Canetta P., Andeen N.K. et al. Diagnostic approach to glomerulonephritis with fibrillar IgG deposits and light chain restriction. Kidney Int. Rep. 2021. 6. 936-45.
2. Rosenstock J.L., Markowitz G.S. Fibrillary glomerulonephritis: An update. Kidney Int. Rep. 2019. 4. 917-22.
3. Klomjit N., Alexander M.Р., Zand Ladan. Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9). Kidney360. 2020. 1. 1002-1013.
4. Ando M., Ohashi K., Akiyama H. et al. Chronic kidney disease in long term survivors of myeloablative allogenic haematopoietic cell transplantation: prevalence and risk factors. Nephrol. Dial. Transplant. 2010. 25. 278-82.
5. Hatamizadeh P. Introducing nephrocardiology. Clin. J. Am. Soc. Nephrol. 2022. 17. 311-3.
6. Andeen N.K., Yang H.Y., Dai D.F., MacCoss M.J., Smith J.D. Dnaj Homolog subfamily B member 9 is a putative autoantigen in fibrillary GN. J. Am. Soc. Nephrol. 2018. 29. 231-239.
7. Andeen N.K., Troxell M.L., Riazy M. et al. Fibrillary glomerulonephritis: clinicopathologic features and atypical cases from a multi-institutional Cohort. Clin. J. Am. Soc. Nephrol. 2019. 14. 1741-1750.
8. Bae J., Won Y.J., Lee B.W. Non-albumin proteinuria (NAP) as a complementary marker for diabetic kidney disease (DKD). Life. 2021. 11(224). 1-12.
9. Nasr S.Н., Chavez O., Dasari S., Thesis D.Т., Vrana J.А., Fatima H., et al. Donor-derived allect 2 amyloidosis and recurrent fibrillary glomerulonephritis in a transplant allograft. Kidney Med. 2021. 3(3). 433-37.
10. Park J.Н., Kim B.R., Chun B.G., Kim M.Н., Shin H.S., Jung Y.S. et al. Coexistence of fibrillary glomerulonephritis in a patient with multiple myeloma. Intern. Med. 2012. 51. 1379-1381.
11. Fisher P.W., Ho L.Т., Goldschmidt R., Semerdjian R.J., Rutecki G.W. Familial mediterranean fever, inflammation and nephrotic syndrome: fibrillary glomerulopathy and the M6801 missence mutation. BMC Nephrol. 2003. 41-7.
12. Javaid M.М., Denley H., Tagboto S. Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy. BMC Nephrol. 2007. 8 (7). 1-6.
13. Pliquett R.U., Mohr P., Mukhtar B., Girndt M., Markau S. Plasmaphresis leading to remission of refractory nephrotic syndrome due to fibrillary glomerulonephritis: a case report. J. Med. Case Rep. 2012. 6. 116. 1-6.
14. Navaro-Antolin J., Quereda C., Mampaso F., Gonzalo A., Rivera M., Orte L. et al. Rapidly progressive fibrillary glomerulonephritis and cutaneous T-cell lymphoma. Nephron. 1996. 73. 107-8.
15. Adapa S., Konala V.М., Naramala S., Nast C.C. Multiple morphological phenotypes of monoclonal immunoglobulin disease on renal biopsy: significant of treatment. Clin. Nephrol. 2020. 8. 17-24.
16. Sung W.K., Jeong J.U., Bang K.T. et al. Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy. Kidney Res. Clin. Pract. 2015. 117-9.
17. Her M.Y., Kang M.S., Kim D.Y. Fibrillary glomerulonephritis in a patient with rheumatoid arthritis. Letters to Editors. Clin. Exp. Rheumatol. 2008. 26(1). 158.
18. Joffy S., Cathro H.Р., Bellizzi A.М., Balogun R.A. Renal clinico-pathology teaching case: Fibrillary glomerulonephritis. Tropical J. Nephrol. 2008. 3(2). 115-8.
19. Watanabe K., Nakai K., Hosokawa N. et al. A case of fibrillary glomerulonephritis with fibril deposition in the arteriolar wall and a family history of renal disease. Case Rep. Nephrol. Dial. 2017. 7. 26-33.
20. Fillippone E.J., Chmielewski C., Gulati R., Newman E., Faber J.L. Do novo fibrillary glomerulonephritis (FGN) in a renal transplant with chronic hepatitis B. Case Rep. Transpl. 2013. 1-5.
21. Lodhi M.U., Saleem T.S., Usman M.S. et al. Fibrillary glomerulonephritis in a patient with sjogren’s syndrome. Cureus. 2018. 10 (4). 1-7.
22. Gielen G.А.L., Wetzels J.F.M., Steenbergen E.J., Mudde A.H. Fibrillary glomerulonephritis in a patient with type 2 diabetes mellitus. Netherland J. Med. 2006. 64 (4). 119-123.
23. Jeyabalan A., Batal I., Piras D., Morris H.K., Appel G.B. Familial fibrillary glomerulonephritis in living related kidney transplantation. Kidney Int. Rep. 2021. 6. 239-42.
24. Momose A., Nakajima T., Chiba S. et al. A case of fibrillary glomerulonephritis associated with thrombotic microangiopathy and anti-glomerular basement membrane antibody. Nephron Extra. 2015. 5. 30-8.
25. Dolores Sánchez de la Nieta García M., González López L., Castro Fernández P. Fibrillary glomerulonephritis simulating glome–rular basal antimembrane antibody disease with associated thrombo–tic microangiopathy and ANCAp. Nefrologia. 2021. 907. 1-3.
26. Nebuloni M., Gendreni A., Tosoni A., Caruso S., di Belgiojoso G.B. Fibrillary glomerulonephritis with prevalent IgA deposition associated with undifferentiated connective tissue disease: A case report. Nephrol. Dial. Transplant. Plus. 2010. 3. 57-59.
27. Cheungpasitporn W., Zacharek C.С., Fervenza F.С., Cornell L.D., Sethi S., Herrera Hernandez L.Р. et al. Clin. Kidney J. 2016. 9 (1). 97-101.
28. Nilajgi S., Killen J.Р., Baer R., Renaut P., Mantha M. Fibrillary glomerulonephritis: presenting as crescentric glomerulonephritis causing rapidly progressive renal disease. Nephrol. Dial. Transplant. Plus. 2011. 4. 413-5.
29. Sethi S., Adeyi O.А., Rennke H.G. A case of fibrillary glomerulonephritis with linear immunoglobulin G staining of the glomerular capillary walls. Arch. Pathol. Lab. Med. 2001. 125. 534-6.
30. Kfoury H.K. Fibrillary glomerulonephritis: A diagnosis not to be missed. Saudi Kidney Dis. Transpl. 2021. 23 (6). 1246-50.
31. Shah H.Н., Thakkar J., Pullman J.М., Mathew A.T. Fibrillary glomerulonephritis presenting as crescentric glomerulonephritis. Indian J. Nephrol. 2017. 27 (2). 157-60.
32. Huerta A., Segovia B., Hernandez A. et al. When the finding of glomerular fibrils in patients with nephrotic syndrome leads to an erroneous diagnosis. Nephrol. Dial. Transplant. Plus. 2009. 2. 63-6.
33. Alpers C.Е., Kowalewska J. Fibrillary glomerulonephritis and immunotactoid glomerulopathy. J. Am. Soc. Nephrol. 2008. 19. 34-37.
34. Vera Mendez F.J., Molina Nunez M., Hernandez Garcia M.А., Garcia Solano J. Fibrillary and immunotactoid glomerulonephritis: report of a case and review of the literature. An. Med. Interna. 2005. 22(1). 35-8.
35. Marin L.L., Mendez R.В., Ferrer B.L. et al. Fibrillary glomerulonephritis: presentation of case and differential diagnostics with diseases from deposits. Morfovirtual 2016; Third Virtual Congress of Morphological Sciences. Third Scientific Conference of the Santiago Ramón y Cajal Chair. 1–15.
36. Churg J., Venkataseshan V.S. Fibrillary glomerulonephritis without immunoglobulin deposits in the kidney. Kidney Int. 1993. 44. 837-42.
37. Uchida T., Komatsu S., Sakai T., Kojima A., Iwama S., Sugisaki K., et al. CEN Case Rep. 2021. 10. 442-7.
38. Amir-Ansari B., O̕Donnell P., Nelson S.R., Cairns H.S. Fibrillary glomerulonephritis in a patient with adenocarcinoma of stomach. Nephrol. Dial. Transplant. 1999. 12. 210-11.
39. Lerner G., Singer G., Larsen C.Р., Caza T.N. Immunoglobulin-negative fibrillary glomerulonephritis masked in diabetic nephropathy: A case report and discussion of a diagnostic pitfall. Glomerular dis. 2021. 1-11.
40. Fernandez de Larrea C., Rovira M., Mascaro J.J.М. et al. Generalized cutis laxa and fibrillar glomerulopathy resulting from IgG deposition in IgG-lambda monoclonal gammopathy: pulmonary hemorrhage during stem cell mobilization and complete hematological response with bortezomib and dexamethasone therapy. Europ. J. Hematol. 2008. 82. 154-8.
41. Leibler C., Moktefi A., Matignon M., Debiais-Delpec C., Oniszczuk J., Sahali D. et al. Rituximab and fibrillary glomerulonephritis: Interest B cell reconstitution monitoring. J. Clin. Med. 2018. 7(430). 1-7.
42. Gandhi P., Tang J. Successful treatment of a unique case of congophilic fibrillary glomerulonephritis. Med. 2020. 99(28). 1-3.
43. Masson R.G., Rennke H.G., Gottlieb M.N. Pulmonary he–morrhage in a patient with fibrillary glomerulonephritis. New Engl. J. Med. 1992. 1-4.
44. Kornblihtt L.І., Vassaillu P.S., Heller P.G., Lago N.R., Alvarez C.L., Molinas F.S. Primary myelofibrosis in a patient who developed primary biliary cirrhosis, autoimmune hemolytic anemia and fibrillary glomerulonephritis. Ann. Hematol. 2008. 87. 1019-20.
45. Wu C.К., Leu J.G., Yang A.H., Tarng D.С., Tung H.Y., Chiang S.S. Simultaneous occurrence of fibrillary glomerulonephritis and renal fibrosis in nonmalignant monoclonal gammopathy. BMC Nephrol. 2016. 17. 17. 1-5.
46. Sainz-Prestel V., Hernandez-Perez J., Rojas-Rivera J., Milicua-Munoz J.М., Edigo J., Ortiz A. Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis. Clin. Kidney J. 2013. 6. 510-2.
47. Cheung C.Y., Chan A.О.К., Chan G.P.Т., Iu H.Y.Р., Shek C.С., Chau K.F. Long-term of kidney transplantation in a patient with coexisting lipoprotein glomerulopathy and fibrillary glomerulonephritis. Clin. Kidney J. 2014. 7. 396-8.
48. Sekulic M., Nasr S.Н., Grande J.Р., Cornell L.D. Histologic regression of fibrillary glomerulonephritis: the first report of biopsy-proven spontaneous resolution of disease. Clin. Kidney J. 2017. 10 (6). 738-41.
49. Maroz N., Reuben S., Nadasdy T. Treatment of fibrillary glomerulonephritis with use of repository corticotropin injections. Clin. Kidney J. 2018. 11(6). 788-90.
50. Cantillo J.D.J., Lopez R.D.Р., Andrade R.E. Glomerular deposition disease, regarding a case of fibrillary glomerulonephritis. Biomed. 2009. 29. 539-46.
51. Yumura W., Nitta K., Horita S., Ozu H., Honda K., Nihei H. Nephrotic syndrome associated with fibrillary deposits in the glomeruli. Intern. Med. 1995. 34. 46-50.
52. Suzuki S., Konta T., Koizumi R., Nishida W., Abiko H., Kubota I. Fibrillary glomerulonephritis with hypocomplementemia. Intern. Med. 2003. 42. 719-22.
53. Sundaram S., Mainali R., Norfolk E.R., Shaw IV J.H., Zhang P.L. Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy. Ann. Clin. Lab. Sci. 2007. 37 (4). 370-4.
54. Sehgal R., Sajjad S.M., Thapa J.K. Fibrillary glomerulonephritis in primary sjogren’s syndrome: A rare cause of renal failure. Clin. Med. Res. 2017. 15(3–4). 100-5.
55. Chaudhary A., Gyamlani G., Coosey N.L., Walker P.D., Wall B.M. Successful use of rituximab in fibrillary glomerulopathy. Ren. Fail. 2014. 36 (7). 1151-4.
56. Dussol B., Kaplanski G., Daniel L., Brunet P., Pellissier J.F., Berland Y. Simultaneous occurrence of fibrillary glomerulopathy and AL amyloid. Nephrol. Dial. Transplant. 1998. 13. 2630-2.
57. Ichikawa H., Ikeda S., Hashimoto M., Nagake Y., Hironaka K., Shikata K. et al. Fibrillary glomerulonephritis in a patient with familial sensorineural deafness. Nephrology. 1997. 3. 381-4.
58. Coroneos E., Truong L., Olivero J. Fibrillary glomerulonephritis associated with hepatitis C viral infection. Am. J. kidney Dis. 1997. 29 (1). 132-5.
59. Ray S., Rouse K., Appis A., Novak R., Haller N.A. Fibrillary glomerulonephritis with hepatitis C viral infection and hypocomplementemia. Ren. Fail. 2008. 30. 759-62.
60. Kim H.J., Kang S.W., Park S.J., Kim T.Н., Kang M.S., Kim Y.H. Fibrillary glomerulonephritis associated with Behcet’ Syndrome. Ren. Fail. 2012. 34(5). 637-9.
61. Soma J., Sato K., Nakaya I., Yahata M., Sakuma T., Sato H. Systemic non-amyloiditic fibril deposition disease: a probable variant form of fibrillary glomerulonephritis. Clin. Nephrol. 2011. 75 (1). 74-9.
62. Asakawa T., Asou M., Hara S., Ehara T., Araki M. Fibrillary glomerulopathy with high level of myeloperoxidase — ANCA: A case report. Case Rep. Nephrol. 2020. 2020. Article ID 6343521.
63. Gonzalez-Cabrera F., Henriquez-Palop F., Ramirez-Puga A. et al. The occurrence or fibrillary glomerulonephritis in patients with diabetes mellitus may not be coincidental: A report of four cases. Case Rep. Med. 2013. 2013. Article ID 935172.
64. Tsui C., Dokouhaki P., Prasad B. Fibrillary glomerulonephritis with crescentric and necrotizing glomerulonephritis and concurrent thrombotic microangiopathy. Case Rep. Nephrol. Dial. 2018. 8. 182-91.
65. Adey D.В., Macpherson B.R., Groggle G.C. Glomerulonephritis with associated hypocomplementemia and crescents: An unusual case of fibrillary glomerulonephritis. J. Am. Soc. Nephrol. 1995. 6. 171-6.
66. Rostagno A., Vidal R., Kumar A., Chuba J., Neiderman G., Gold L., et al. Fibrillary glomerulonephritis related to serum fibrillar immunoglobulin-fibronectin complexes. Am. J. Kidney Dis. 1996. 28(5). 676-84.
67. Hsu B.G., Chang C.H., Chiang S.S., Yang A.H. Fibrillary glomerulonephritis. Chinese Med. J. (Taipei). 2001. 64. 419-25.
68. Bircan Z., Toprak D., Kilicaslen I. et al. Factor H deficiency and fibrillary glomerulopathy. Nephrol. Dial. Transplant. 2004. 19. 727-30.
69. Cheung S.F., Yue T.Т., Lee K.C. Fibrillary glomerulopathy; report of a case and review of the literature. Hong Kong J. Nephrol. 1991. 1(1). 64-7.
70. Khorsan R., Ruan Q.N. Fibrillary glomerulonephritis. Proceed UCLA Health. 2021. 25. 1-2.
71. Nasr S.Н., Valeri A.М., Cornell L.D., Fidler M.Е., Sethi S., Leung N. et al. Fibrillary glomerulonephritis: A report of 66 cases from a single institution. Clin. J. Am. Soc. Nephrol. 2011. 6. 775-84.
72. Nasr S.Н., Dasari S., Lieske J.С., Benson L.М., Vanderboom P.М., Holtz-Hepplemann C.J. et al. Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients. Kidney Int. 2019. 95. 1269-72.
73. Andeen N.K., Smith K.D., Vasilescu E.R., Bata I. Fibrillary GN is associated with HLA-DR7 and HLA-B35 antigens. Kidney Int. Rep. 2020. 5. 1325-7.
74. Said S.М., Best Rocha A., Valeri A.М., Sandid M., Ray A.S., Fidler M.Е. et al. Characteristics of patients with coexisting with DNAjB9-associated fibrillary glomerulonephritis and IgA nephropathy. Clin. Kidney J. 2021. 6. 1681-90.
75. Payan Schober F., Jobson M.А., Poulton C.J., Singh H.K., Nickeleti V., Falki R.J. et al. Clinical features and outcomes of a racially diverse population with fibrillary glomerulonephritis. Am. J. Nephrol. 2017. 45. 248-56.
76. Marinaki S., Tsiakas S., Liapis G. et al. Clinicopathologic features and treatment outcomes of patients with fibrillary glomerulonephritis. Medicine. 2021. 100 (20). 1-6.
77. Dasari S., Alexander M.Р., Vrana J.А., Theis J.D., Mils J.R., Negron V. et al. DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN. J. Am. Soc. Nephrol. 2018. 29. 51-56.